C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2006
10/31/2006	US7129334 Polypeptides; from snake venom; wound healing agents
10/31/2006	US7129333 Glycoprotein synthesis
10/31/2006	US7129332 Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
10/31/2006	US7129207 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
10/31/2006	US7129078 DNA encoding androgen receptor fragment
10/31/2006	US7129065 bHLH-PAS proteins, genes thereof and utilization of the same
10/31/2006	US7129064 Canine hepatocyte growth factor
10/31/2006	US7129063 Junction-enriched and -associated protein (JEAP); antibodies for visualizing localization
10/31/2006	US7129062 Matrix attachment regions and methods for use thereof
10/31/2006	US7129061 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand or "TRELL", a polypeptide which is a member of the Tumor Necrosis Factor Family
10/31/2006	US7129060 Export systems for recombinant proteins
10/31/2006	US7129059 decarbonylation of secondary amides in the presence of hydrolase enzymes, cofactors and optionally stabilizer agents, to form primary amines
10/31/2006	US7129053 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool
10/31/2006	US7128913 Erythropoietin conjugates
10/31/2006	US7128910 Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequences and uses thereof
10/31/2006	CA2336561C Monoclonal antibody to lymphocyte-associated cell surface protein
10/31/2006	CA2332183C Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use
10/31/2006	CA2293819C A method for in vitro molecular evolution of protein function
10/31/2006	CA2250047C Monoclonal antibodies binding human growth hormone (hgh)
10/31/2006	CA2239729C Cell separation composition, kit and method
10/31/2006	CA2180830C Anti-annexin-v monoclonal antibody, process for producing the same, and use thereof
10/31/2006	CA2129733C Mammalian expression systems for hcv proteins
10/26/2006	WO2006113522A2 Methods of detecting hepatitis c virus
10/26/2006	WO2006113277A2 Multivalent soluble tyrokinase receptor that bind angiogenic factor
10/26/2006	WO2006112147A1 Transgenic bird producing erythropoietin and method of constructing the same
10/26/2006	WO2006091209A3 Bispecific binding agents for modulating biological activity
10/26/2006	WO2006076343A8 Mycobacteria expressing hiv-1 and malaria antigens
10/26/2006	WO2006073921A3 Compositions and methods for enhanced dendritic cell maturation and function
10/26/2006	WO2006010033A3 Detection of nucleic acids to assess risk for bovine spongiform encephalopathy
10/26/2006	WO2005106011A3 Process for preparing dipeptidyl iv inhibitors and intermediates therefor
10/26/2006	WO2002101008A3 Intracellular signaling molecules
10/26/2006	US20060242724 Receptor
10/26/2006	US20060242721 Gene families associated with liver cancer
10/26/2006	US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis
10/26/2006	US20060241284 Transmembrane protein amigo and uses thereof
10/26/2006	US20060241039 reduce blood clotting activity by reducing thrombin generation; thrombotic diseases
10/26/2006	US20060241026 Novel cyclic peptides and use thereof as anti-microbial agents
10/26/2006	US20060241025 Biodegradable glucosamine-muramyl peptides for apoptosis modulation
10/26/2006	US20060241015 Cancer genes
10/26/2006	US20060240535 Carbonyl reductase from lactococcus lactis
10/26/2006	US20060240533 Assembly for the stabilisation of vertebral bodies of the spine
10/26/2006	US20060240526 Amino acid substitution in position 36; brain bleeding, hemorrhage, trauma or injury; genetic engineering and expression; biodrugs, anticoagulants
10/26/2006	US20060240525 Factor VII or VIIa - Like Molecules
10/26/2006	US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
10/26/2006	US20060240523 Endogenous and non-endogenous versions of human G protein-coupled receptors
10/26/2006	US20060240522 Process for bacterial production of polypeptides
10/26/2006	US20060240521 DNA sequences for regulating transcription
10/26/2006	US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity
10/26/2006	US20060240519 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
10/26/2006	US20060240517 Novel receptor nucleic acids and polypeptides
10/26/2006	US20060240516 Interacting polypeptide comprising a heptapeptide pattern and a cell penetration domain
10/26/2006	US20060240515 Soluble fragments of the SARS-CoV spike glycoprotein
10/26/2006	US20060240514 Fermentation of product for growth medium with reduced levels of animal meat or dairy product
10/26/2006	US20060240513 Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom
10/26/2006	US20060240512 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents
10/26/2006	US20060240511 a DNA fragment that encodes an immunogenic variant of human estrogen receptor-2 (HER-2) polypeptide, a EGFR (endothelial growth factor receptor) family of proteins, capable of raising an immune response in humans; vaccines
10/26/2006	US20060240510 Method for designing peptides
10/26/2006	US20060240509 Myrothecium sp transformation and expression system
10/26/2006	US20060240506 Method for isolating and culturing unculturable microorganisms
10/26/2006	US20060240502 GTP cyclohydrolase II as a target for fungicides
10/26/2006	US20060240501 Removing fructosyl group from a fructosylated peptide or protein by reacting with an aqueous Pyrus pyrifolia, Vitis vinifera, or Daucus carota extract containing an enzyme that removes the fructose without removing an amino acid residue; detecting reaction products
10/26/2006	US20060240491 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
10/26/2006	US20060240472 Pigment protein
10/26/2006	US20060240470 Gene causative of Rothmund-Thomson syndrome and gene product
10/26/2006	US20060240465 CNG2B: a novel human cyclic nucleotide-gated ion channel
10/26/2006	US20060240464 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
10/26/2006	US20060240459 ClCKb mutation as a diagnostic and therapeutical target
10/26/2006	US20060240439 Modified polymerases for improved incorporation of nucleotide analogues
10/26/2006	US20060240432 Transmembrane serine protease probes for use as evaluative tool in detection of nervous system stem cells and treatment of neurodegenerative diseases; regenerative medicine; tissue engineering
10/26/2006	US20060240425 Genes and polypeptides relating to myeloid leukemia
10/26/2006	US20060240421 Genetic polymorphisms sensitively predicting adverse drug reactions (adr) and drug efficacy
10/26/2006	US20060240415 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays
10/26/2006	US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis
10/26/2006	US20060240029 Chlamydia pneumoniae antigens
10/26/2006	US20060240027 Conjugated with toxins, enzymes, radioactive compounds, and hematogenous cells; use in staging and diagnosis; treatment of metastasis
10/26/2006	US20060240025 isolated polypeptide encoded by an isolated nucleic acid molecule as antitumor biodrugs; modulation of chemokine, cytokine expression
10/26/2006	US20060240024 T cell regulation
10/26/2006	US20060240023 Apoptosis-associated protein and use thereof
10/26/2006	US20060240021 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
10/26/2006	US20060240020 Inhibition of complement activation
10/26/2006	US20060240015 Recombinant antibody against human insulin-like growth factor
10/26/2006	US20060240012 For treating inflammation and immunopathy; rheumatoid arthritis
10/26/2006	US20060240004 Methods for treating tweak-related conditions
10/26/2006	US20060240003 Humanised antibodies to the epidermal growth factor receptor
10/26/2006	US20060239997 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
10/26/2006	US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections
10/26/2006	US20060239988 Neuronal regeneration and compound administration methods
10/26/2006	US20060239984 Promoter to il-18bp, its preparation and use
10/26/2006	US20060239969 Isolated nucleic acid molecule; enhancing immunity to the protein product expressed by the HER2/neu tumor-associated antigen
10/26/2006	US20060239965 Fusion polypeptide comprising a hyaluronan-binding polypeptide fused to a heterologous polypeptide such as a growth factor, an enzyme that activates a prodrug, an angiogenesis inhibitor, a chemoattractant polypeptide or a matrix metalloproteinase inhibitor; anticancer agents
10/26/2006	US20060239912 Carrier molecules
10/26/2006	US20060239910 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
10/26/2006	CA2608410A1 A novel .beta.-galactoside-.alpha.2, 3-sialyltransferase, a gene encoding thereof, and a method for producing thereof
10/25/2006	EP1715057A2 Methods of modifying carbohydrate moieties
10/25/2006	EP1715046A2 New polypeptide, DNA encoding the polypeptide, recombinant vector bearing the DNA and recombinant virus utilizing the recombinant vector as well as use thereof
10/25/2006	EP1715045A2 Recombinant antibodies for human therapy
10/25/2006	EP1715038A1 Antibody targeting osteoclast-associated protein
10/25/2006	EP1714980A1 Human receptor proteins, related reagents and methods
10/25/2006	EP1714973A1 Substances k01-0509 and process for producing the same

1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 1125